Phae II study of hexamethylmelamine in women with advanced breast cancer refractory to standard cytotoxic therapy.
作者信息
Denefrio J M, Vogel C L
出版信息
Cancer Treat Rep. 1978 Jan;62(1):173-5.
PMID:414835
Abstract
摘要
相似文献
1
Phae II study of hexamethylmelamine in women with advanced breast cancer refractory to standard cytotoxic therapy.
Cancer Treat Rep. 1978 Jan;62(1):173-5.
2
Phase II evaluation of hexamethylmelamine in advanced breast cancer: a Southwest Oncology Group study.
Cancer Treat Rep. 1979 Aug;63(8):1359-61.
3
Phase I--II study of hexamethylmelamine plus dibromodulcitol in refractory carcinoma of the breast.六甲蜜胺加二溴卫矛醇治疗难治性乳腺癌的I-II期研究
Cancer Treat Rep. 1979 Jan;63(1):141-2.
4
5
Phase II trial of hexamethylmelamine in ovarian carcinoma resistant to alkylating agents.六甲蜜胺治疗对烷化剂耐药的卵巢癌的II期试验。
Cancer Treat Rep. 1979 Jan;63(1):137-8.
6
Phase II study of hexamethylmelamine for disseminated prostatic carcinoma.
Cancer Clin Trials. 1981 Fall;4(3):309-12.
7
Hexamethylmelamine in alkylating agent-resistant ovarian carcinoma.六甲蜜胺在耐烷化剂卵巢癌中的应用
Cancer. 1978 Nov;42(5):2157-61. doi: 10.1002/1097-0142(197811)42:5<2157::aid-cncr2820420511>3.0.co;2-7.
8
[Effectiveness of ftorafur and hexamethylmelamine in advanced breast cancer].氟尿嘧啶和六甲蜜胺在晚期乳腺癌中的疗效
Vopr Onkol. 1978;24(8):60-5.
9
Phase II study of hexamethylmelamine in refractory Hodgkin's disease, other lymphomas, and chronic lymphocytic leukemia.
Cancer Treat Rep. 1981 Nov-Dec;65(11-12):1027-9.
10
Randomized phase II trial of hexamethylmelamine versus pentamethylmelamine in carcinoma of the bilharzial bladder.
Cancer Treat Rep. 1984 May;68(5):793-4.
引用本文的文献
1
Altretamine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in cancer chemotherapy.六甲蜜胺。对其药效学和药代动力学特性以及在癌症化疗中的治疗潜力的综述。
Drugs. 1995 Jun;49(6):932-53. doi: 10.2165/00003495-199549060-00007.
2
Chemotherapy of breast cancer.乳腺癌的化疗
Med Oncol Tumor Pharmacother. 1984;1(3):169-92. doi: 10.1007/BF02934139.
Zotero 插件